Navigation Links
Alcoa Unveils Partnership for Carbon Capture Technology Pilot Test Designed to Turn Emissions Into Beneficial Commercial Products
Date:4/7/2011

NEW YORK, April 7, 2011 /PRNewswire/ -- Alcoa (NYSE: AA) today announced a new pilot program, in collaboration with Codexis, Inc. (Nasdaq: CDXS) and CO2 Solution Inc. (TSX-V: CST), focused on carbon capture technology designed to sequester industrial carbon emissions, neutralizing the material to create a commercially viable product.

The project is the latest innovation from the world's leading aluminum producer and will be funded by Alcoa along with approximately $13.5 million in funding from the U.S. Department of Energy (DOE) received from an award with the National Energy Technology Laboratory (NETL). This funding was made available by the American Recovery and Reinvestment Act (ARRA).

The pilot program, part of Alcoa's ongoing commitment to enhance its operational sustainability, will use an innovative and proprietary in-duct scrubber technology to capture emissions. The collaboration is intended to devise solutions that treat and utilize a primary byproduct of the aluminum manufacturing process known as alkaline clay, or bauxite residue, as well as other alkaline industrial residuals. This pilot project will test a scrubbing process that combines treated flue gas, enzymes and alkaline clay to create a mineral-rich neutralized product that could be used for environmental reclamation projects. The project is emblematic of how Alcoa is leveraging its extensive R&D capabilities and utilizing game-changing technologies from companies such as Codexis and CO2 Solution to advance sustainable solutions that can have an impact beyond Alcoa's operations.

"Our mission at Alcoa is to create a more sustainable world through innovative solutions and responsible operations," said Kevin Anton, Alcoa's Chief Sustainability Officer. "Finding ways to turn industrial waste into beneficial products will create a more sustainable society for generations to come. We are committed to this project and partnership because it epitomizes our belief that sustainable technologies are fundamental for the maintenance of vital resources and, therefore, for our business."

Scientists and engineers from Alcoa Technical Center in Pittsburgh will lead the three-year project, which has an investigation phase that runs through December.  Upon successful completion of this phase, the project will proceed to the pilot testing phase. The DOE grant was received as part of an initiative to find ways of converting captured carbon dioxide emissions from industrial sources into useful products such as fuels, plastics, cement and fertilizers.  

"We are very pleased to be expanding deployment of our carbon capture technology with Alcoa," said Dr. Alan Shaw, Codexis president and CEO. "We recently reported significant progress in our first program to reduce CO2 emissions from coal-fired power plants. With this agreement, we are expanding to a second large market where our technology can add real economic value, and where it may convert industrial waste to new, valuable products."

Glenn Kelly, CO2 Solution president and CEO, commented on the new partnership, saying, "We are delighted to be building on our relationship with Alcoa to support this important technology development and further expand into U.S. and global markets. This represents a significant new application of our technology, and we are pleased to be working with Alcoa as a global leader towards its realization."

Codexis and CO2 Solution have been collaborating since late 2009 on the development of custom carbonic anhydrase (CA) enzymes and processes that could significantly decrease the cost of carbon dioxide capture from industrial sources. CA is an enzyme that catalyzes the transfer of carbon dioxide in nature, and program results to date show that the technology can be used to create and deploy CA biocatalysts with substantially improved stability and performance under industrial conditions.

For more information, visit www.alcoa.com, www.codexis.com and www.co2solution.com.

About Alcoa Alcoa is the world's leading producer of primary aluminum, fabricated aluminum and alumina. In addition to inventing the modern-day aluminum industry, Alcoa innovation has been behind major milestones in the aerospace, automotive, packaging, building and construction, commercial transportation, consumer electronics and industrial markets over the past 120 years. Among the solutions Alcoa markets are flat-rolled products, hard alloy extrusions, and forgings, as well as Alcoa® wheels, fastening systems, precision and investment castings, and building systems in addition to its expertise in other light metals such as titanium and nickel-based super alloys. Sustainability is an integral part of Alcoa's operating practices and the product design and engineering it provides to customers. Alcoa has been a member of the Dow Jones Sustainability Index for eight consecutive years and approximately 75 percent of all of the aluminum ever produced since 1888 is still in active use today. Alcoa employs approximately 59,000 people in 31 countries across the world. More information can be found at www.alcoa.com.

About Codexis, Inc.Codexis is a clean technology company. Codexis develops optimized biocatalysts that make industrial processes faster, cleaner and more efficient. Codexis' technology is commercialized with leading global pharmaceutical companies and in development for advanced biofuels with Shell and in carbon capture. Other potential markets include chemicals and water treatment. For more information, see www.codexis.com.

Codexis Forward-Looking StatementsThis press release contains forward-looking statements relating to Codexis' research in carbon capture technology.  You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond our control and that could materially affect actual results. Factors that could materially affect actual results can be found in Codexis' Annual Report on Form 10-K dated February 10, 2011 including under the caption "Risk Factors." Codexis expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law.

About CO2 Solution Inc.CO2 Solution is an innovator in the field of enzyme-enabled carbon capture and has been actively working to develop and commercialize the technology for power plants and other large stationary sources of carbon pollution.  In the process, CO2 Solution has built an extensive patent portfolio covering the use of carbonic anhydrase, or analogues thereof, for the efficient post-combustion capture of carbon dioxide with low-energy aqueous solvents.  Further information about CO2 Solution can be found at www.co2solution.com

Forward-looking StatementsCertain statements in this news release may be forward-looking. These statements relate to future events or CO2 Solution's future economic performance and reflect the current assumptions and expectations of management. Certain unknown factors may affect the events, economic performance and results of operation described herein. CO2 Solution undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable law.MEDIA CONTACTS:AlcoaCO2 Solution Inc.Codexis, Inc.Mike Belwood

+1.812.604.0530

mike.belwood@alcoa.com

Thom Skinner

+1.418.842.3456

thom.skinner@co2solution.com

Lyn Christenson

+1.650.421.8144

lyn.christenson@codexis.com
'/>"/>

SOURCE Alcoa; Codexis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Oregon Tourism Commission Unveils New Online Customer Service Training Program
2. NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting
3. Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention
4. OmegaGenesis Unveils Novel Nanotechnology Platform With Broad Biomedical Applications
5. Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain
6. Boehringer Ingelheim Unveils Diabetes Pipeline
7. GNC Unveils Study Results for First and Only Nitric Oxide Product Clinically Proven to Improve Physical Performance at NSCA Conference in Las Vegas
8. Cleveland Clinic Unveils Top 10 Medical Innovations for 2010
9. Eurotech Unveils New Diabetes Care Management Solution
10. Ethicon Endo-Surgery Unveils Full Energy Portfolio for First Time at American College of Surgeons Clinical Congress
11. Siemens Unveils New Hearing Loss Options at SPLASH: ADAs 2009 Convention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... OSWEGO, Ore. , Dec. 5, 2016   ... the BioInsight clinical study. The study evaluates the safety ... insertion procedure in an office setting. BioMonitor ... ® technology that is placed underneath a patient,s ... fibrillation and syncope (fainting). Atrial fibrillation is a leading ...
(Date:12/5/2016)... --  TrainerMD , the first HIPAA compliant software collaboration platform for ... Styku . Styku, a California -based ... users world-class, real-time 3D body scanning and analysis. Together with its ... hear and feel their health like never before. ... , , ...
(Date:12/5/2016)... 5, 2016  Recently Zymo Research announced an ... known as Horvath,s Clock. Based on this technology, ... service to academic and biopharma scientific researchers to ... other than sperm. The service quantifies ... age versus chronological age following drug treatments and ...
Breaking Medicine Technology:
(Date:12/6/2016)... ... December 06, 2016 , ... U.S. Security Associates (USA) ... 125 for their industry leading training methods that engage their associates and link ... the global elite in employer-sponsored training and development programs. , “The 2017 Training ...
(Date:12/5/2016)... (PRWEB) , ... December 06, 2016 , ... For many ... Lithuanian poetry , both thick and thin. The beauty of the Lithuanian language ... Trafford Publishing). , In this poetry book, Zubinas lyrically explores all aspects of a ...
(Date:12/5/2016)... ... 2016 , ... “Epilepsy Awareness,” which can be found at ... conversation about epilepsy, bearing down on the social stigma and lack of public ... epilepsy within their lifetime. With such a large percentage of people affected, it’s ...
(Date:12/5/2016)... ... ... BSI and Brenntag Canada have been appointed by Chr. Hansen as their ... fruits and beverage colorants effective November 1, 2016. , “The ... product portfolio,” said Steve Brauer, President of Brenntag Specialties, Inc. “Representing Chr. Hansen will ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... ("GPP") portfolio company, today announced it has acquired the assets of Frankfurt, ... previously a subsidiary of Chiltern International and focuses on clinical trial drug ...
Breaking Medicine News(10 mins):